Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fast tracking informative clinical trials: lessons for mental health.

Journal article

Gold SM. et al, (2023), Lancet psychiatry

Facilitating participation in clinical trials during pregnancy.

Journal article

Vousden N. et al, (2023), Bmj, 380

A Pragmatic Randomized Feasibility Trial of Influenza Vaccines

Journal article

Johansen ND. et al, (2023), Nejm evidence, 2

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.

Journal article

Nuffield Department of Population Health Renal Studies Group None. and SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium None., (2022), Lancet, 400, 1788 - 1801

Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2022), N engl j med

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Journal article

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845

Data provenance and integrity of health-care systems data for clinical trials.

Journal article

Murray ML. et al, (2022), Lancet digit health, 4, e567 - e568

Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.

Journal article

Peto L. et al, (2022), Adv biol regul

Allocated but not treated: the silent 16%

Other

Horby P. et al, (2022), Lancet, 399, 1776 - 1776

Allocated but not treated: the silent 16% - Authors' reply.

Other

Horby P. et al, (2022), Lancet, 399, 1775 - 1776

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur heart j, 43, 1416 - 1424

Load More